Objective: The purpose of this study was to investigate the interaction between the G-protein beta-3 (GNB3) 825C4T polymorphism and physical activity in relation to prevalent obesity and hypertension. Research methods and procedures: The GNB3 825C4T genotype was measured in a sample of 14 716 African Americans (AAs) and whites from the Atherosclerosis Risk in Communities (ARIC) study, and logistic regression was used to test for genetic effects and gene-environment interactions. Results: The GNB3 825C4T variant was not independently associated with prevalent obesity or hypertension in either AA or whites. However, we observed a significant interaction (Po0.001) between this variant and physical activity in predicting obesity status in AAs. In AAs who were active, each 825T allele was associated with a 20% lower prevalence of obesity (odds ratio (OR) ¼ 0.80, 95% confidence interval (CI) ¼ 0.689-0.937, P ¼ 0.005), whereas each 825T allele was associated with a 23% greater prevalence of obesity for low-active individuals (OR ¼ 1.23, 95% CI ¼ 1.06-1.44, P ¼ 0.008). We also found a significant interaction between the GNB3 825C4T polymorphism, obesity status and physical activity in predicting hypertension in the AA subjects. AA homozygotes for the 825T allele who were both obese and had a low activity level were 2.7 times more likely to be hypertensive, compared to non-obese, active 825C homozygotes (OR ¼ 2.71, 95% CI ¼ 1.19-6.17, Po0.02). Discussion: Our findings suggest that the variation within the GNB3 gene may interact with physical activity level to influence obesity status and, together with obesity and physical activity, the GNB3 825C4T variant may influence hypertension prevalence in AAs.
Introduction
Each year, over 300 000 deaths are attributed to improper diet and lack of exercise, and sedentary lifestyle has long been established as an independent risk factor for many types of complex diseases. 1 Although good nutrition and exercise are recommended for all, not everyone responds to these lifestyle factors in a similar manner. Thus, understanding the interaction between environmental factors, such as physical activity and DNA sequence variation has taken on increasing importance. The G-protein beta-3 subunit gene (GNB3) plays an important role in sodium processing, and intracellular signaling by G-proteins is also an essential step in the formation of mature adipocytes. 2 Thus, the GNB3 gene has been proposed as a candidate gene for both obesity and hypertension. The GNB3 gene encodes the Gb3 subunit of heterotrimeric G proteins. A polymorphism of the GNB3 gene, 825C4T (dbSNP rs5443, Ser275Ser), is tightly associated with a splice variant that results in a deletion of 41 amino acids in exon 9 of the G-protein. This substitution generates a loss of one of seven of the beta propeller blades and is thought to cause increased G-protein activation. 3 Numerous studies have investigated the role of this variant within the GNB3 gene and human disease. Although several reports have provided evidence for significant associations between this variant and both hypertension and obesity, other studies have reported that the gene is not associated with either. 4 Of the many studies that have investigated this gene polymorphism, most have small or highly specialized types of subject samples, and few studies to date have considered the interaction between the GNB3 825C4T variant and physical activity. Therefore, we investigated the interaction between baseline physical activity level and the GNB3 825C4T polymorphism in relation to prevalent obesity and hypertension in a bi-ethnic sample of over 14 000 adult men and women.
Research methods and procedures

Subjects
The Atherosclerosis Risk in Communities (ARIC) study is a population-based cohort, consisting of 15 792 subjects, aged 45-65 years at baseline. Subjects were selected by probability sampling from four study communities: Forsyth County, NC; Jackson, MS; northwestern suburbs of Minneapolis, MN; and Washington County, MD. The cohort was intended to be representative of the race/ethnic make-up of the communities, except in Jackson, MS, where all participants are African American (AA). ARIC subjects who did not allow the use of their DNA for research purposes (n ¼ 45), who were not AA or white (n ¼ 47), and those subjects missing genotype (n ¼ 851) and or covariate phenotype data (n ¼ 260) were removed from this analysis. AAs living in Minneapolis, MN, or Washington County, MD (n ¼ 55) were also excluded. After exclusions, the remaining data set consisted of 1429 AA males, 2299 AA females, 5199 white males and 5789 white females. Individuals with prevalent coronary heart disease (CHD) (n ¼ 1099), prevalent stroke (n ¼ 67) and/or transient ischemic attack (TIA) (n ¼ 264) were also excluded from analyses in which hypertension was the primary outcome.
Clinical and laboratory measurements
Baseline examinations began in 1987 and comprised a home interview, clinical examination and blood laboratory determinations. Cardiovascular risk factors, socioeconomic factors and family medical history were assessed during the home interview. A detailed description of the ARIC study design and methods is published elsewhere. classified as obese. 6 Three blood pressure measurements were taken using a random zero sphygmomanometer and the average of the last two was used for analysis. A greater whitecoat effect (i.e. greater stress associated with a physical examination) has been observed in older patients 7 and prevalence of white-coat hypertension has been shown to decrease as severity of hypertension increases. 8, 9 to reduce misclassification of hypertension status, hypertension was defined as systolic blood pressure greater than or equal to 160 mm Hg, diastolic blood pressure greater than or equal to 95 mm Hg or antihypertensive medication use in the 2 weeks before their baseline examination. All following measures were from baseline examinations. Diabetes status was defined as a fasting serum glucose level X126 mg/dl, a non-fasting glucose X200 mg/dl or a self-reported history of or treatment for diabetes. Cigarette smoking status was defined as current smoking versus former or never smoking. Plasma total cholesterol levels were measured by enzymatic methods, and low-density lipoprotein cholesterol was calculated. 10 Prevalent CHD was defined as evidence of a previous myocardial infarction (by electrocardiography at rest or self-reported physician diagnosis) or having had at least one of the following procedures: heart or arterial surgery, a coronary bypass or angioplasty of any coronary artery. Prevalent stroke or TIA was defined by a selfreported history of stroke/TIA diagnosed by a physician. Activity levels were quantified using the ARIC/Baecke physical activity questionnaire, a slightly modified version 11 of the original Baecke physical activity questionnaire 12 that comprises non-continuous activity scores ranging from 1 (low) to 5 (high) for activity in work, sport and leisure categories. A total index score was calculated based on the summary of the three indices.
Genotyping methods
Genotyping of the GNB3 825C4T variant was performed using the TaqMan allelic discrimination assay (Applied Biosystems, Foster City, CA, USA). An 80-bp product was amplified using 0.9 mM each of the forward primer 5 0 -TCCCACGAGAGCATCATCTG-3 0 and the reverse primer 5 0 -TCGTCGTAGCCAGCGAATAGT-3 0 , 0.2 mM each of the sequence-specific probes 5 0 -6FAM-CATCACGTCCGTGG CCTTCTCC-TAMRA-3 0 and 5 0 -VIC-CATCACGTCTGTGG CCTT CTCCCT-TAMRA-3 0 , 1 Â TaqMan Universal PCR master mix containing AmpliTaq Gold DNA polymerase and 3 ng DNA in a 5.5 mL reaction volume. Allele detection and genotype calling were performed using the ABI 7900HT and the Sequence Detection System software (Applied Biosystems, Foster City, CA, USA).
Statistical methods
Analyses were carried out with the Stata SE software package version 8.0 (College Station, TX, USA). Allele frequencies of GNB3 were estimated by gene counting. Agreement of the race-specific GNB3 allele frequencies with Hardy-Weinberg equilibrium expectations was tested using a w 2 goodness-offit test. Multivariate logistic regression was used to evaluate the single locus genotype association with prevalence of obesity and hypertension. Odds ratios (ORs) were calculated for each of the single locus genotypes using an additive effect of the 825T allele and assessed for significance by the Wald w Gene-environment interaction and the GNB3 gene ML Grove et al statistic.
Covariates in the race-specific analysis included age, gender, diabetes, smoking status, total cholesterol and physical activity level. Analyses were also repeated without diabetes and cholesterol as covariates and without excluding the prevalent CHD, TIA and stroke individuals from the hypertension analyses. The results were very similar to those presented here (data not shown). Tests of interaction were performed that included main effects for GNB3 and physical activity and/or obesity and a multiplicative two-way interaction term for gene by physical activity or gene by obesity.
To test the combined effects of obesity and physical activity level on hypertension, a joint variable was created for the two measures that represent four groups: (1) non-obese, high-active individuals, (2) non-obese, low-active individuals, (3) obese, high-active individuals and (4) obese, lowactive individuals. The non-obese, high-active group served as the referent in analyses of gene by obesity/physical activity interactions. Likelihood ratios tests comparing models with and without the interaction terms were used to test the significance of the interactions. Post hoc analyses of significant interaction tests were further investigated using stratified analyses.
Results
Descriptive characteristics by race and gender are presented in Table 1 . AAs were significantly younger and had a significantly higher BMI and body weight than the white individuals. There was also a significantly higher prevalence of smoking, diabetes, hypertension, stroke and TIA in AAs than in whites.
Genotype frequencies were within race-specific HardyWeinberg equilibrium expectations, and both allele and genotype frequencies were significantly different between AAs and whites (Table 2) , with the T825 allele more common among AAs and the C825 allele more common among whites. Owing to the reciprocal allele frequencies, all analyses were performed in a race-specific manner. Allele and genotype frequencies were not significantly different between obese and non-obese or between hypertensive and non-hypertensive individuals (Table 3) , regardless of race group. Individuals missing genotypes were not phenotypically different from those with genotypes (data not shown).
The total activity index score (ranging from 3 to 15) from the ARIC/Baecke physical activity questionnaire was used for these analyses. Individuals were classified as low-active if their total activity score was below the race-specific median and high-active if their total activity score was above the race-specific median (AA ¼ 6.5 and whites ¼ 7.2) or if any single activity index score was X4. AAs had significantly lower summary physical activity scores than in whites In logistic regression models, the GNB3 825C4T variant was not independently associated with obesity prevalence in AAs or whites, after controlling for age, gender, smoking status, diabetes, total cholesterol and physical activity level. Nevertheless, we observed a significant interaction (Po0.001) between this variant and physical activity in predicting obesity status in AAs. Because of the significant interaction, we conducted post hoc analyses, stratified by activity status (CC genotype class used as referent in the additive model), to examine the effect of genotype on obesity. In AAs who were active, each 825T allele was associated with a 20% lower prevalence of obesity (OR ¼ 0.80, 95% CI ¼ 0.689-0.937, P ¼ 0.005), whereas each 825T allele was associated with a 23% higher obesity prevalence in AAs who were low-active (OR ¼ 1.23, 95% CI ¼ 1.06-1.44, P ¼ 0.008) (Figure 1 ). There was no significant interaction between the 825C4T variant and physical activity level in relation to obesity in whites (data not shown).
The GNB3 825C4T variant was not associated with prevalent hypertension in either AAs or whites, and there was no significant interaction between physical activity and this variant in predicting hypertension in either subject sample. Nevertheless, we found a significant multiplicative interaction (P ¼ 0.02) between GNB3 genotype, obesity and physical activity in predicting hypertension status in AAs.
Using race-specific dummy-coded logistic regression models, homozygotes for the 825T allele who were obese and had a low-activity level had a more than twofold risk of being hypertensive than 825C homozygotes who were non-obese and active (OR ¼ 2.71, 95% CI ¼ 1.19-6.17, P ¼ 0.018). In post hoc analyses stratified by genotype and using the non-obese/ active individuals within each genotype class as the referent (Table 4) , obesity/activity was not associated with hypertension prevalence in AA homozygous 825C subjects. However, carriers of the 825T allele who were also obese or inactive had greater prevalent hypertension than non-obese, active 825T carriers, with the greatest risk for hypertension in these stratified analyses associated with 825T homozygotes who were also obese and inactive (OR ¼ 2.46, 95% CI ¼ 1.86-2.35). We did not observe a similar interaction between the GNB3 825C4T variant and physical activity or obesity in relation to hypertension in whites, and unlike the AAs, physical inactivity was significantly associated with increased prevalence of hypertension in whites, regardless of genotype. Gene-environment interaction and the GNB3 gene ML Grove et al
Discussion
We investigated the association of variation within the GNB3 gene with obesity and hypertension, including interaction with physical activity, in a population-based sample of AA and white men and women. The GNB3 825C4T variant was not independently associated with either obesity or hypertension in AAs or whites, but we provide evidence for a possible gene-physical activity interaction in relation to obesity and a significant combined effect of physical activity and obesity by gene interaction in relation to hypertension in AAs. The protein product of the GNB3 gene plays a critical role in sodium processing and total body fluid homeostasis by directing the trafficking of sodium/potassium channels in and out of the cell membrane. 13, 14 In addition, intracellular signaling by G-proteins is an essential step in the formation of mature adipocytes. 2 The 825C4T polymorphism in exon 10 of the GNB3 gene is associated with a splice variant, 3 and most evidence proposes that the mutated form of the protein increases normal G-protein signal transduction. Although many factors contribute to the development of obesity or hypertension, genes and the interaction between genes and environments appear to play a substantial role in their etiology. We found that the GNB3 825C4T polymorphism is associated with prevalent obesity in AAs, but only in the context of physical activity level. During physical activity, catecholamines bind to beta-adrenergic receptors and catalyze the mobilization of glucose and fatty acids that are needed to fuel muscle movement. 19 The GNB3
825C4T polymorphism creates an altered protein product that may negatively affect interaction with beta-adrenergic receptors during physical activity, 20 possibly leading to a decrease in response to catecholamines, and consequently, to altered energy utilization and adipose homeostasis. 17 We found that obesity was increased only when carriers of the GNB3 825T allele were also inactive, suggesting that this genetic variant may play a role in mediating the effects of physical activity on obesity status in AAs from the ARIC study.
Other studies have reported positive associations between the GNB3 825C4T polymorphism and obesity in populations of Germans, 2 Chinese, black South Africans 21 and Canadian Nunavut Inuit, 22 whereas several studies have reported no association between this gene variant and obesity, [23] [24] [25] [26] [27] including ARIC whites. Few studies have considered the effect of gene-physical activity interaction when testing the GNB3 825C4T polymorphism for association to disease. Although we found no association with the GNB3 825C4T variant in whites, our results for AAs are consistent with a study of a primiparous German women by Gutersohn et al.
28
, in which 825T homozygotes had a significantly greater BMI when compared with C allele carriers, but only in the low-active individuals. Investigators from the HERI-TAGE family study reported that the GNB3 825C4T polymorphism was not associated with body composition phenotypes in either blacks or whites before induction of 20-week endurance program. Nevertheless, there were significant differences in change in fat mass and body fat percentage in blacks only on completion of the exercise program when stratified by the GNB3 genotype, with TT homozygotes having the largest decrease in these phenotypes and the CC homozygotes showing little or no decrease. 29 Our results would also predict that TT homozygotes would be most likely to respond to exercise training, as this is the group in which inactivity is most strongly associated with obesity and hypertension. Conversely, Poston et al. 30 reported that African immigrants and AAs that were 825T homozygotes were more obese than the heterozygotes and 825C homozygotes, regardless of physical activity level. Gene-environment interaction and the GNB3 gene ML Grove et al
Studies testing the association of the GNB3 825C4T polymorphism with hypertension have produced mixed results, with both positive and negative findings in a variety of populations. 3, [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] One could argue that the inconsistency in reports for both obesity and hypertension are attributed to type I errors, misclassification, differing definitions of hypertension used in analyses 4 and differing allele frequencies between populations. It may then be critically important to assess the effects of genetic variation within the context of environments and behaviors that play an essential role in hypertension etiology. In addition to other risk factors such as age and dietary sodium intake, 48 the epidemiologic literature has strongly established a link between obesity and physical inactivity and increased risk for hypertension. Nevertheless, when stratifying by genotype, AAs with two copies of the 825C allele had essentially no greater risk for hypertension with greater levels of obesity and inactivity, whereas those with one or two copies of the 825T allele had increased risk for hypertension in relation to obesity and inactivity (Table 4) . Because the 825C allele is the least frequent in AAs, these findings suggest that 825C homozygosity may confer some level of protection from hypertension, even in the face of obesity and a sedentary lifestyle. Siffert et al. 21 have proposed that consistent reports that link the 825T allele to obesity and hypertension imply that the 825T allele may contribute to obesity-related hypertension. 2, 49 Our findings of significant associations between the C825T variant and obesity and hypertension, both traits associated with the metabolic syndrome (MetS), are supported by studies in which this polymorphism has been correlated with the prevalence of MetS in Oji-Cree adults and with hypertriglyceridemic waist in Canadian aboriginals. 50, 51 Previous studies have shown an association between GNB3 and obesity and/or hypertension in white populations ranging in sample size from 197 to 2052. 2, 32 Despite having a large powerful sample of whites (n ¼ 10 988) and testing the effect of the GNB3 C825T polymorphism within the context of both physical activity and obesity, we found no effect of the variant with hypertension or obesity outcomes. These results are consistent with those of another study in 7518 Danes which investigated components of the MetS. 52 Our negative results may be owing to the environmental/cultural heterogeneity of our white sample as the ARIC white cohort was drawn from three distinct regions of the United States. Genetic heterogeneity is unlikely to be a factor in the analysis. Our AA cohort is drawn primarily from Jackson, Mississippi, with a small portion from North Carolina and comprises a highly homogeneous sample, both in terms of genetic admixture and cultural/environmental factors. Although our findings support the concept that genes and environments can interact to produce differential disease outcomes in different physiologic and behavioral environments, there are limitations to our study. We have used a cross-sectional study design that does not allow for causality conclusions to be made. For example, obesity may contribute to the decrease in physical activity, just as a decrease in physical activity may contribute to the increase in obesity. Intervention studies of physical activity to reduce obesity and hypertension stratified by GNB3 genotype would be useful for dissecting this complex relationship. In addition, we used the total index score from the self-reported ARIC/Baecke physical activity questionnaire, which may not precisely characterize physical activity levels within the ARIC AA cohort. The separate indices have been validated primarily in Caucasian populations, 53, 54 but the total score has not been validated in a repeatability study in whites or AAs. It is also possible that the lower sample number of AA CC homozygotes did not yield enough power to detect the obesity/physical activity by gene effect in prevalent hypertension. The biological plausibility of the analyses is well justified by the literature, and our a priori hypotheses were that the GNB3 C825T variant would interact with physical activity to influence obesity and hypertension. Our initial analyses led us to investigate further whether the effects of the C825T polymorphism on hypertension were mediated through its effects on obesity. P-values were not adjusted for multiple testing using Bonferroni or other types of correction, thus it is possible that our observations may be due to chance. Although further investigation of gene-environment interactions is needed, our findings suggest that information regarding genotype may help to inform treatment decisions for patients with hypertension, particularly among AAs.
